Participants 68 119 5
in patients with poorly controlled type 2 diabetes.
Participants 195 231 5
patients with type 2 diabetes (T2DM)
Participants 258 412 6
multinational, open-label trial included subjects treated for T2DM with metformin ± sulphonylurea, who had glycated haemoglobin (HbA1c) levels of 7.5
Participants 735 994 6
%.
RESULTS The mean [standard deviation (s.d.)] age of the participants was 57 (9) years, the duration of diabetes was 9 (6) years, body mass index was 31.9 (4.2) kg/m(2) and HbA1c level was 9.0 (1.1)%. Equal numbers (n = 489) were allocated to glar
Participants 995 1037 3
ine and liraglutide. Similar numbers of su
Participants 1168 1198 3
observed (p = 0.44). Subje
Participants 1837 1873 3
ION Adding either insulin glargine o
